Parabilis Medicines, Inc. (PBLS)

NASDAQ: PBLS · Real-Time Price · USD

31.96

+0.14 (0.44%)

At close: Jul 28, 2026, 4:00 PM EDT

31.96

0.00 (0.00%)

Pre-market: Jul 29, 2026, 4:58 AM EDT

Parabilis Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	26.5	25.3
Research & Development	125.58	100.83
Total Operating Expenses	152.08	126.13
Operating Income	-152.08	-126.13
Interest Income	3.39	6.41
Interest Expense	-1.52	-1.49
Other Non-Operating Income (Expense)	4.33	3.29
Total Non-Operating Income (Expense)	6.19	8.21
Pretax Income	-145.89	-117.91
Net Income	-145.89	-117.91
Net Income Attributable to Preferred Dividends	41.04	43.57
Net Income to Common	-186.93	-161.48
Net Income Growth	-	-
Shares Outstanding (Basic)	2	2
Shares Outstanding (Diluted)	2	2
Shares Change	4.59%	-
EPS (Basic)	-92.40	-83.48
EPS (Diluted)	-92.40	-83.48
EPS Growth	-	-
Free Cash Flow	-124.02	-104.49
Free Cash Flow Growth	-	-
Free Cash Flow Per Share	-61.30	-54.02
EBITDA	-149.58	-124.02
EBIT	-152.08	-126.13

SEC Filings: 10-K · 10-Q